Form 4: Core Scientific Director Jordan Levy Acquires 48,700 Shares of Common Stock

Director Jordan Levy of Core Scientific, Inc. purchased 48,700 shares of common stock at an average price of $10.1957 on August 20, 2024.

Summary

• On August 20, 2024, Jordan Levy, a director of Core Scientific, Inc., acquired 48,700 shares of common stock.
• The purchase was made at a weighted average price of $10.1957 per share.
• The total number of shares beneficially owned by Levy following the transaction is 223,939.
• The shares were purchased in multiple transactions with prices ranging from $10.135 to $10.27.
• Levy has committed to providing full information regarding the number of shares purchased at each separate price within that range upon request.

Sentiment

Score: 7

Explanation: A director purchasing shares is generally a positive sign, suggesting confidence in the company's future. However, it's a single transaction and doesn't provide a comprehensive view of the company's overall health.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This filing reflects insider trading activity, which is closely monitored by investors for signals about a company's prospects. Director purchases are generally viewed more favorably than sales.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive signal.

Key Dates